Access brought to you by: LOCKSS

Cardiology Clinical Trials

No Benefit to Renal Artery Stenting Seen in CORAL Trial
Edoxaban Noninferior to Warfarin in the ENGAGE AF-TIMI 48 Trial
Immediate Targeted Blood Pressure Reduction Does Not Improve Outcomes in Acute Stroke
Third-Generation ZES Matches EES in Efficacy and Safety, without Evidence of Longitudinal Deformation in an All-Comer Population
All-Cause Mortality and Major Stroke Significantly Reduced with Iliofemoral CoreValve Replacement
SORT-OUT VI: Zotarolimus-Eluting Stent Noninferior to Biolimus-Eluting Stent
Prehospital Bivalirudin Improved Outcomes versus Heparin in Patients with Myocardial Infarction
Similar Outcomes with Two-Stent and Provisional Stenting Techniques in Large Side Branch Bifurcation Lesions
Prehospital Cooling Does Not Improve Outcomes in Cardiac Arrest
Tryton Two-Stent Strategy Safe, but Did Not Meet Noninferiority Endpoint

Pages